All of the vaccines were under emergency use authorization starting with Pfizer-BioNTech which was authorized under the Emergency Use Authorization on December 11, 2020. The new Biden administration came in the New Year and tensions built over the next months as vaccine hesitant quadrants of society avoided the vaccine. Many assumed if the vaccine would be approved then that would alleviate stress and concern. However, another suspected agenda was planned mandates both at the local and federal level. So on August 23, 2021 the FDA moved forward with an unorthodox decision. They both approved Comirnaty, the market name of the Pfizer-BioNTech mRNA vaccine but also declared that people in America would continue to be vaccinated with BNT162b2, the investigational product still under EUA as there was only the later in supply. Technically they are the same product but this decision was unorthodox. Many people though once the approval happened product liability would be a factor but that wasn’t’ the case. Due to the emergency PREP Act for example no vaccine makers or other health care value chain members could be liable. The government had a limited liability fund for any injuries capped at $50,000.